Top

Open Access 10-12-2024 | Type 1 Diabetes | Position Statement

The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)

Authors: Othmar Moser, Dessi P. Zaharieva, Peter Adolfsson, Tadej Battelino, Richard M. Bracken, Bruce A. Buckingham, Thomas Danne, Elizabeth A. Davis, Klemen Dovč, Gregory P. Forlenza, Pieter Gillard, Sabine E. Hofer, Roman Hovorka, Peter G. Jacobs, Julia K. Mader, Chantal Mathieu, Kirsten Nørgaard, Nick S. Oliver, David N. O’Neal, John Pemberton, Rémi Rabasa-Lhoret, Jennifer L. Sherr, Harald Sourij, Martin Tauschmann, Jane E. Yardley, Michael C. Riddell

Published in: Diabetologia

Abstract

Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provide additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology. It discusses each commercially available AID system individually and provides guidance on their use in PA. Additionally, it addresses different glucose responses to PA and provides stratified therapy options to maintain glucose levels within the target ranges for these age groups.

Graphical Abstract

Available only for authorised users

Adolfsson P, Taplin CE, Zaharieva DP et al (2022) ISPAD Clinical Practice Consensus Guidelines 2022: exercise in children and adolescents with diabetes. Pediatr Diabetes 23(8):1341–1372. https://doi.org/10.1111/PEDI.13452CrossRefPubMedPubMedCentral

Riddell MC, Gallen IW, Smart CE et al (2017) Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol. 5:377–390. https://doi.org/10.1016/S2213-8587(17)30014-1CrossRefPubMed

Colberg SR, Sigal RJ, Yardley JE et al (2016) Physical activity/exercise and diabetes: a position statement of the American diabetes association. Diabetes Care 39(11):2065–2079. https://doi.org/10.2337/DC16-1728CrossRefPubMedPubMedCentral

Moser O, Riddell MC, Eckstein ML et al (2020) Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society f. Diabetologia 63(12):2501–2520. https://doi.org/10.1007/s00125-020-05263-9CrossRefPubMed

Phillip M, Nimri R, Bergenstal RM et al (2023) Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev 44(2):254–280. https://doi.org/10.1210/ENDREV/BNAC022CrossRefPubMed

Zaharieva DP, Morrison D, Paldus B, Lal RA, Buckingham BA, O’Neal DN (2023) Practical aspects and exercise safety benefits of automated insulin delivery systems in type 1 diabetes. Diabetes Spectr 36(2):127–136. https://doi.org/10.2337/DSI22-0018CrossRefPubMedPubMedCentral

O’Neal DN, Zaharieva DP, Morrison D, McCarthy O, Nørgaard K (2024) Exercising safely with the MiniMedTM 780G automated insulin delivery system. Diabetes Technol Ther 26(S3):84–96. https://doi.org/10.1089/dia.2023.0420CrossRefPubMed

Zimmer RT, Auth A, Schierbauer J et al (2023) (Hybrid) closed-loop systems: from announced to unannounced exercise. Diabetes Technol Ther. https://doi.org/10.1089/DIA.2023.0293CrossRefPubMed

Sherr JL, Heinemann L, Fleming GA et al (2023) Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetologia 66(1):3–22. https://doi.org/10.1007/s00125-022-05744-zCrossRefPubMed

10.

Garg SK, McVean JJ (2024) Development and future of automated insulin delivery (AID) systems. Diabetes Technol Ther 26:1–6. https://doi.org/10.1089/DIA.2023.0467/FORMAT/EPUBCrossRefPubMed

11.

Garcia-Tirado J, Colmegna P, Villard O et al (2023) Assessment of meal anticipation for improving fully automated insulin delivery in adults with type 1 diabetes. Diabetes Care 46(9):1652–1658. https://doi.org/10.2337/DC23-0119CrossRefPubMedPubMedCentral

12.

Shalit R, Minsky N, Laron-Hirsh M et al (2023) Unannounced meal challenges using an advanced hybrid closed-loop system. Diabetes Technol Ther 25(9):579–588. https://doi.org/10.1089/DIA.2023.0139CrossRefPubMed

13.

Parent C, Lespagnol E, Berthoin S et al (2022) Barriers to physical activity in children and adults living with type 1 diabetes: a complex link with real-life glycemic excursions. Can J Diabetes 47(2):P124-132. https://doi.org/10.1016/j.jcjd.2022.10.006CrossRef

14.

Zaharieva DP, Turksoy K, McGaugh SM et al (2019) Lag time remains with newer real-time continuous glucose monitoring technology during aerobic exercise in adults living with type 1 diabetes. Diabetes Technol Ther 21(6):313–321. https://doi.org/10.1089/dia.2018.0364CrossRefPubMedPubMedCentral

15.

Li A, Riddell MC, Potashner D, Brown RE, Aronson R (2019) Time lag and accuracy of continuous glucose monitoring during high intensity interval training in adults with type 1 diabetes. Diabetes Technol Ther 21(5):286–294. https://doi.org/10.1089/DIA.2018.0387CrossRefPubMed

16.

Guillot FH, Jacobs PG, Wilson LM et al (2020) Accuracy of the Dexcom G6 glucose sensor during aerobic, resistance, and interval exercise in adults with type 1 diabetes. Biosensors 10(10):138. https://doi.org/10.3390/bios10100138CrossRefPubMedPubMedCentral

17.

Da Prato G, Pasquini S, Rinaldi E et al (2022) Accuracy of CGM systems during continuous and interval exercise in adults with type 1 diabetes. J Diabetes Sci Technol 16(6):1436–1443. https://doi.org/10.1177/19322968211023522CrossRefPubMed

18.

Moser O, Sternad C, Eckstein ML et al (2022) Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: a pooled analysis. Diabetes Obes Metab 24(3):522–529. https://doi.org/10.1111/DOM.14609CrossRefPubMed

19.

Moser O, Mader J, Tschakert G et al (2016) Accuracy of continuous glucose monitoring (CGM) during continuous and high-intensity interval exercise in patients with type 1 diabetes mellitus. Nutrients 8(8):489. https://doi.org/10.3390/nu8080489CrossRefPubMedPubMedCentral

20.

Oliva-Lozano JM, Alacid F, López-Miñarro PA, Muyor JM (2022) What are the physical demands of sexual intercourse? A systematic review of the literature. Arch Sex Behav 51:1397–1417. https://doi.org/10.1007/s10508-021-02246-8CrossRefPubMedPubMedCentral

21.

Yardley JE (2022) Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity. Diabetologia 65(12):1994–1999. https://doi.org/10.1007/S00125-022-05781-8CrossRefPubMed

22.

Toghi-Eshghi SR, Yardley JE (2019) Morning (fasting) vs afternoon resistance exercise in individuals with type 1 diabetes: a randomized crossover study. J Clin Endocrinol Metab 104(11):5217–5224. https://doi.org/10.1210/JC.2018-02384CrossRefPubMed

23.

Fahey AJ, Paramalingam N, Davey RJ, Davis EA, Jones TW, Fournier PA (2012) The effect of a short sprint on postexercise whole-body glucose production and utilization rates in individuals with type 1 diabetes mellitus. J Clin Endocrinol Metab 97(11):4193–4200. https://doi.org/10.1210/JC.2012-1604CrossRefPubMed

24.

Justice TD, Hammer GL, Davey RJ et al (2015) Effect of antecedent moderate-intensity exercise on the glycemia-increasing effect of a 30-sec maximal sprint: a sex comparison. Physiol Rep 3(5):e12386. https://doi.org/10.14814/PHY2.12386CrossRefPubMedPubMedCentral

25.

Myette-Coté É, Molveau J, Wu Z et al (2023) A randomized crossover pilot study evaluating glucose control during exercise initiated 1 or 2 h after a meal in adults with type 1 diabetes treated with an automated insulin delivery system. Diabetes Technol Ther 25(2):122–130. https://doi.org/10.1089/DIA.2022.0338CrossRefPubMedPubMedCentral

26.

McCarthy OM, Christensen MB, Kristensen KB et al (2023) Automated insulin delivery around exercise in adults with type 1 diabetes: a pilot randomized controlled study. Diabetes Technol Ther 25(7):476–484. https://doi.org/10.1089/DIA.2023.0009CrossRefPubMed

27.

Dovc K, Bergford S, Fröhlich-Reiterer E et al (2023) A comparison of faster insulin aspart with standard insulin aspart using hybrid automated insulin delivery system in active children and adolescents with type 1 diabetes: a randomized double-blind crossover trial. Diabetes Technol Ther 25(9):612–621. https://doi.org/10.1089/DIA.2023.0178CrossRefPubMedPubMedCentral

28.

Moser O, Muller A, Aberer F et al (2023) Comparison of insulin glargine 300 U/mL and insulin degludec 100 U/mL around spontaneous exercise sessions in adults with type 1 diabetes: a randomized cross-over trial (ULTRAFLEXI-1 Study). Diabetes Technol Ther 25(3):161–168. https://doi.org/10.1089/DIA.2022.0422CrossRefPubMed

29.

Laffel LM, Aleppo G, Buckingham BA et al (2017) A practical approach to using trend arrows on the dexcom G5 CGM system to manage children and adolescents with diabetes. J Endocr Soc 1(12):1461–1476. https://doi.org/10.1210/JS.2017-00389CrossRefPubMedPubMedCentral

30.

Moser O, Eckstein ML, Mueller A et al (2019) Pre-exercise blood glucose levels determine the amount of orally administered carbohydrates during physical exercise in individuals with type 1 diabetes-a randomized cross-over trial. Nutrients 11(6):1287. https://doi.org/10.3390/NU11061287CrossRefPubMedPubMedCentral

31.

Moser O, Mueller A, Andritz E et al (2024) Performance of automated insulin delivery systems during a winter ski camp in children and adolescents with type 1 diabetes: the InSki trial. Diabetologia 67(1 Suppl):490 (Abstract). https://doi.org/10.1007/s00125-024-06226-0CrossRef

32.

Paldus B, Morrison D, Zaharieva DP et al (2022) A randomized crossover trial comparing glucose control during moderate-intensity, high- intensity, and resistance exercise with hybrid closed-loop insulin delivery while profiling potential additional signals in adults with type 1 diabetes. Diabetes Care 45(1):194–203. https://doi.org/10.2337/FIGSHARE.16892092CrossRefPubMed

33.

Morrison D, Zaharieva DP, Lee MH et al (2022) Comparable glucose control with fast-acting insulin aspart versus insulin aspart using a second-generation hybrid closed-loop system during exercise. Diabetes Technol Ther 24(2):93–101. https://doi.org/10.1089/DIA.2021.0221CrossRefPubMed

34.

Moser O, Sanfilippo S, Grothoff A et al (2024) Sicherheit und Effizienz des mylife CamAPS FX Hybrid Closed-Loop Systems während maximaler Ausbelastungstests bei Kindern und Jugendlichen mit Diabetes Mellitus Typ 1: eine explorative präliminäre Analyse der InLoopChild Studie. Diabetolgie Stoffwechsel 19(S1):S41 (Abstract) [article in German]. https://doi.org/10.1055/s-0044-1785312

35.

Messer LH, Buckingham BA, Cogen F et al (2022) Positive impact of the bionic pancreas on diabetes control in youth 6–17 years old with type 1 diabetes: a multicenter randomized trial. Diabetes Technol Ther 24(10):712–725. https://doi.org/10.1089/DIA.2022.0201.PUBCrossRefPubMedPubMedCentral

36.

Russell SJ, Beck RW, Damiano ER et al (2022) Multicenter, randomized trial of a bionic pancreas in type 1 diabetes. N Engl J Med 387(13):1161–1172. https://doi.org/10.1056/NEJMOA2205225CrossRefPubMed

37.

Russell SJ, El-Khatib FH, Nathan DM, Magyar KL, Jiang J, Damiano ER (2012) Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care 35(11):2148–2155. https://doi.org/10.2337/DC12-0071/-/DC1CrossRefPubMedPubMedCentral

38.

Russell SJ, El-Khatib FH, Sinha M et al (2014) Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 371(4):313–325. https://doi.org/10.1056/NEJMOA1314474CrossRefPubMedPubMedCentral

39.

Russell SJ, Hillard MA, Balliro C et al (2016) Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol 4(3):233–243. https://doi.org/10.1016/S2213-8587(15)00489-1CrossRefPubMedPubMedCentral

40.

Fushimi E, Aiello EM, Cho S et al (2024) Online classification of unstructured free-living exercise sessions in people with type 1 diabetes. Diabetes Technol Ther. https://doi.org/10.1089/DIA.2023.0528CrossRefPubMed

41.

McClure RD, Alcántara-Cordero FJ, Weseen E et al (2023) Systematic review and meta-analysis of blood glucose response to high-intensity interval exercise in adults with type 1 diabetes. Can J Diabetes 47(2):171–179. https://doi.org/10.1016/J.JCJD.2022.11.006CrossRefPubMed

42.

Zaharieva DP, Messer LH, Paldus B, O’Neal DN, Maahs DM, Riddell MC (2020) Glucose control during physical activity and exercise using closed loop technology in adults and adolescents with type 1 diabetes. Can J Diabetes 44(8):740–749. https://doi.org/10.1016/j.jcjd.2020.06.003CrossRefPubMed

43.

Mattsson S, Jendle J, Adolfsson P (2019) Carbohydrate loading followed by high carbohydrate intake during prolonged physical exercise and its impact on glucose control in individuals with diabetes type 1-an exploratory study. Front Endocrinol (Lausanne) 10:571. https://doi.org/10.3389/FENDO.2019.00571CrossRefPubMed

44.

Franc S, Benhamou PY, Borot S et al (2021) No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed-loop system for 12 weeks: a post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial. Diabetes Obes Metab 23(9):2170–2176. https://doi.org/10.1111/DOM.14442CrossRefPubMedPubMedCentral

45.

Hanaire H, Franc S, Borot S et al (2020) Efficacy of the Diabeloop closed-loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exercise. Diabetes, Obes Metab 22(3):324–334. https://doi.org/10.1111/DOM.13898CrossRefPubMed

46.

Lee MH, Vogrin S, Paldus B et al (2020) Glucose and counterregulatory responses to exercise in adults with type 1 diabetes and impaired awareness of hypoglycemia using closed-loop insulin delivery: a randomized crossover study. Diabetes Care 43(2):480–483. https://doi.org/10.2337/DC19-1433CrossRefPubMed

47.

Berget C, Sherr JL, DeSalvo DJ et al (2022) Clinical implementation of the Omnipod 5 Automated Insulin Delivery System: key considerations for training and onboarding people with diabetes. Clin Diabetes 40(2):168–184. https://doi.org/10.2337/CD21-0083CrossRefPubMedPubMedCentral

48.

Hughes MS, Kingman RS, Hsu L, Lal RA, Buckingham BA, Zaharieva DP (2023) Swimming with the Omnipod 5 Automated Insulin Delivery System: connectivity in the water. Diabetes Care 46(8):e148–e150. https://doi.org/10.2337/DC23-0470CrossRefPubMedPubMedCentral

49.

Turner LV, Sherr J, Zaharieva DP et al (2024) Activity feature attenuates drop in glucose for individuals with type 1 diabetes using Omnipod® 5 Automated Insulin Delivery System. Diabetes 73(Suppl 1):326-OR. https://doi.org/10.2337/db24-326-OR10CrossRef

50.

Tagougui S, Taleb N, Legault L et al (2020) A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes: announced (with or without bolus reduction) vs unannounced exercise strategies. Diabetologia 63(11):2282–2291. https://doi.org/10.1007/S00125-020-05244-YCrossRefPubMed

51.

McCarthy OM, Christensen MB, Kristensen KB et al (2023) Glycemia around exercise in adults with type 1 diabetes using automated and nonautomated insulin delivery pumps: a switch pilot trial. Diabetes Technol Ther 25(4):287–292. https://doi.org/10.1089/DIA.2022.0542CrossRefPubMed

52.

Morrison D, Paldus B, Zaharieva DP et al (2022) Late afternoon vigorous exercise increases postmeal but not overnight hypoglycemia in adults with type 1 diabetes managed with automated insulin delivery. Diabetes Technol Ther 24(12):873–880. https://doi.org/10.1089/dia.2022.0279CrossRefPubMed

53.

Jayawardene DC, McAuley SA, Horsburgh JC et al (2017) Closed-loop insulin delivery for adults with type 1 diabetes undertaking high-intensity interval exercise versus moderate-intensity exercise: a randomized, crossover study. Diabetes Technol Ther 19(6):340–348. https://doi.org/10.1089/DIA.2016.0461CrossRefPubMed

54.

Franc S, Daoudi A, Pochat A et al (2015) Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study. Diabetes Obes Metab 17(12):1150–1157. https://doi.org/10.1111/DOM.12552CrossRefPubMedPubMedCentral

55.

Reddy R, Wittenberg A, Castle JR et al (2019) Effect of aerobic and resistance exercise on glycemic control in adults with type 1 diabetes. Can J Diabetes 43(6):406-414.e1. https://doi.org/10.1016/J.JCJD.2018.08.193CrossRefPubMed

56.

Riddell MC, Peters AL (2022) Exercise in adults with type 1 diabetes mellitus. Nat Rev Endocrinol 19(2):98–111. https://doi.org/10.1038/S41574-022-00756-6CrossRefPubMed

57.

Chico A, Moreno-Fernández J, Fernández-García D, Solá E (2024) The hybrid closed-loop system Tandem t:slim X2^tm with Control-IQ technology: expert recommendations for better management and optimization. Diabetes Ther 15(1):281–295. https://doi.org/10.1007/S13300-023-01486-2CrossRefPubMed

58.

Adolfsson P, Hanas R, Zaharieva DP, Dovc K, Jendle J (2024) Automated insulin delivery systems in pediatric type 1 diabetes: a narrative review. J Diabetes Sci Technol. https://doi.org/10.1177/19322968241248404CrossRefPubMed

59.

Schoelwer MJ, Robic JL, Gautier T et al (2020) Safety and efficacy of initializing the control-IQ artificial pancreas system based on total daily insulin in adolescents with type 1 diabetes. Diabetes Technol Ther 22(8):594–601. https://doi.org/10.1089/DIA.2019.0471CrossRefPubMed

60.

Breton MD, Cherñavvsky DR, Forlenza GP et al (2017) Closed-loop control during intense prolonged outdoor exercise in adolescents with type 1 diabetes: the artificial pancreas Ski study. Diabetes Care 40(12):1644–1650. https://doi.org/10.2337/DC17-0883CrossRefPubMedPubMedCentral

61.

Ekhlaspour L, Forlenza GP, Chernavvsky D et al (2019) Closed loop control in adolescents and children during winter sports: use of the Tandem Control-IQ AP system. Pediatr Diabetes 20(6):759–768. https://doi.org/10.1111/PEDI.12867CrossRefPubMedPubMedCentral

62.

Mameli C, Rigamonti A, Felappi B et al (2024) Performance of tandem control IQ during outdoor physical activity in children and adolescents with type 1 diabetes. Diabetes Technol Ther 26(2):112–118. https://doi.org/10.1089/DIA.2023.0324CrossRefPubMed

63.

Bergford S, Riddell MC, Gal RL et al (2024) Predicting hypoglycemia and hyperglycemia risk during and after activity for adolescents with type 1 diabetes. Diabetes Technol Ther. https://doi.org/10.1089/DIA.2024.0061CrossRefPubMed

64.

Moser O, Tschakert G, Mueller A et al (2015) Effects of high-intensity interval exercise versus moderate continuous exercise on glucose homeostasis and hormone response in patients with type 1 diabetes mellitus using novel ultra-long-acting insulin. PLoS One 10(8):e0136489. https://doi.org/10.1371/JOURNAL.PONE.0136489CrossRefPubMedPubMedCentral

65.

Riddell MC, Zaharieva DP, Tansey M et al (2019) Individual glucose responses to prolonged moderate intensity aerobic exercise in adolescents with type 1 diabetes: the higher they start, the harder they fall. Pediatr Diabetes 20(1):99–106. https://doi.org/10.1111/pedi.12799CrossRefPubMed

66.

Roy-Fleming A, Taleb N, Messier V et al (2019) Timing of insulin basal rate reduction to reduce hypoglycemia during late post-prandial exercise in adults with type 1 diabetes using insulin pump therapy: a randomized crossover trial. Diabetes Metab 45(3):294–300. https://doi.org/10.1016/J.DIABET.2018.08.002CrossRefPubMed

67.

Riddell MC, Li Z, Gal RL et al (2023) Examining the acute glycemic effects of different types of structured exercise sessions in type 1 diabetes in a real-world setting: the Type 1 Diabetes and Exercise Initiative (T1DEXI). Diabetes Care 46(4):704–713. https://doi.org/10.2337/DC22-1721CrossRefPubMedPubMedCentral

68.

Bergford S, Riddell MC, Jacobs PG et al (2023) The type 1 diabetes and exercise initiative: predicting hypoglycemia risk during exercise for participants with type 1 diabetes using repeated measures random forest. Diabetes Technol Ther 25(9):602–611. https://doi.org/10.1089/DIA.2023.0140CrossRefPubMedPubMedCentral

69.

Li Z, Calhoun P, Rickels MR et al (2024) Factors affecting reproducibility of change in glucose during exercise: results from the type 1 diabetes and EXercise initiative. J Diabetes Sci Technol. https://doi.org/10.1177/19322968241234687CrossRefPubMedPubMedCentral

70.

Riddell MC, Scott SN, Fournier PA et al (2020) The competitive athlete with type 1 diabetes. Diabetologia 63:1475–1490. https://doi.org/10.1007/s00125-020-05183-8CrossRefPubMedPubMedCentral

Title: The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Authors: Othmar Moser
Dessi P. Zaharieva
Peter Adolfsson
Tadej Battelino
Richard M. Bracken
Bruce A. Buckingham
Thomas Danne
Elizabeth A. Davis
Klemen Dovč
Gregory P. Forlenza
Pieter Gillard
Sabine E. Hofer
Roman Hovorka
Peter G. Jacobs
Julia K. Mader
Chantal Mathieu
Kirsten Nørgaard
Nick S. Oliver
David N. O’Neal
John Pemberton
Rémi Rabasa-Lhoret
Jennifer L. Sherr
Harald Sourij
Martin Tauschmann
Jane E. Yardley
Michael C. Riddell
Publication date: 10-12-2024
Publisher: Springer Berlin Heidelberg
Keywords: Type 1 Diabetes
Glucose Monitoring and Insulin Delivery Devices
Insulins
Endocrinology
Pediatric Endocrinology and Diabetology
Insulins
Hypoglycemia
Published in: Diabetologia
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-024-06308-z

At a glance: The STEP trials

Obesity
Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on adolescent vaping

Springer Medicine

Abstract

Graphical Abstract

Please log in to get access to this content

At a glance: The STEP trials